Skip to main content
Clinical Trials/ITMCTR1900002588
ITMCTR1900002588
Not yet recruiting
Phase 4

A Randomized, Single-blind, Multi-center Clinical Study for Artemisinin-Piperazine and Artemether-Benzolol in the Treatment of Uncomplicated Falciparum Malaria

ConditionsMalaria

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Malaria
Sponsor
Guangzhou University of Chinese Medicine
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Age: 6 months to 60 years old;
  • 2\. Uncomplicated falciparum malaria in microscopic examination;
  • 3\. The number of asexual protozoa is 2000–200 000/µL in high malaria endemic areas,and is 1000–100 000/µL in low malaria endemic areas;
  • 4\. Axillary temperature\>\= 37\.5 degree C or had fevered in 24 hours
  • 5\. Having ability to swallow oral medication;
  • 6\. Having ability and willingness to abide by the protocol during the study and following the study follow\-up;
  • 7\. If the patient is a child, should obtain informed consent form from the parent or guardian.

Exclusion Criteria

  • 1\. According to the definition of WHO(2000\), children under 5 years old with general signs of danger or symptoms of severe falciparum malaria;
  • 2\. Mixed malaria patients in microscopic examination;
  • 3\. According to the WHO (2006\) Child Growth Standard, severely malnourished children;
  • 4\. Fever caused by measles, acute lower respiratory tract infection, severe diarrhea with dehydration, other known chronic or serious diseases (such as heart, kidney or liver disease, AIDS) expect malaria
  • 5\. Other routine medications that interfere with pharmacokinetics of antimalarial drug
  • 6\. Allergic reactions or contraindications to any drug being tested or used as an alternative treatment of the disease;
  • 7\. Pregnancy test positive or lactating women;
  • 8\. Women of childbearing age who are unable or unwilling to take contraceptive measures.

Outcomes

Primary Outcomes

Not specified

Similar Trials